|
HHS Agency Priority Goal on Equity Workgroup (FY 2022-2023)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, ASPE, CDC, CMS, HRSA
|
NIMHD, OEDI
|
The goal of the Agency Priority Goal (APG) Workgroup was to investigate the feasibility of developing the Equity priority area into a viable APG. The workgroup was charged with identifying ongoing activities that align to this priority area and contain components of an APG, and if feasible, developing a draft Impact Statement for submission to HHS leadership and OMB. Agency Priority Goals (APGs) focus the attention of leadership and contributing agencies on achieving critical performance goals for the Department. APGs are required by the Government Performance and Results Act Modernization Act of 2010 (GPRAMA).
|
|
HHS Antiretroviral Treatment Guidelines Panel for Adults and Adolescents with HIV
|
Committee, Work group, Advisory group, or Task Force
|
HRSA, CDC, FDA
|
NIAID
|
The Panel was formed in 1996, to provide guidelines for clinicians for adult and adolescents with HIV. The Panel is a working group of the NIH Office of AIDS Research Council. One of the co-chairs of the Panel is Dr. Cliff Lane of NIAID, the executive secretary is Alice Pau of NIAID. The Panel updates the guidelines annually, and more frequently if needed.
|
|
HHS Behavioral Health Coordinating Council (BHCC) Overdose Prevention Subcommittee
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA, OASH, ASPE
|
NIDA, OD/OSP
|
The National Institutes of Health (National Institute on Drug Abuse; NIDA) Serves as Co-Chair with the Food and Drug Administration (FDA) on this inter-agency subcommittee addressing drug overdose. NIDA participates on its constituent working groups whose topics include: drafting and implementation of the HHS Overdose Prevention Strategy; expanding access to contingency management; addressing pharmacy availability of buprenorphine; determining the public health impact of kratom scheduling; and improving clinician education on controlled substance prescribing.
|
|
HHS Behavioral Health Coordinating Council, Subcommittee on Children and Youth
|
Committee, Work group, Advisory group, or Task Force
|
HRSA, SAMHSA, FDA, OASH, CMS
|
NICHD, NIMH, NIDA
|
Overall, the BHCC is intended to inform the department-wide behavioral health agenda and provide recommendations on agency priorities and strategic planning.
|
|
HHS Biannual Dual Use Research of Concern (DURC) Inventory
|
Resource Development
|
CDC, FDA, OS
|
OD/OSP, CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI
|
Develops the Department of Health and Human Services (HHS) Biannual Dual Use Research of Concern (DURC) inventory reports, as required by the United States Government (USG) Policy for Oversight of Dual Use Research of Concern.
|
|
HHS Biosafety and Biosecurity Coordinating Council (HHS BBCC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
OD/OSP, OD/ORS
|
High-level and formal mechanism for coordinating and collaborating on biosafety and biosecurity issues across the Department of Health and Human Services.
|
|
HHS Border Health Intra-agency Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, FDA, HRSA, OS
|
NICHD, NIA, NIAID, NIDDK, NIMH, NIMHD
|
This intra-agency workgroup allows for the exchange of information and cooperation among the Department of Health and Human Services (HHS) agencies on issues related to border health. The purpose of this group is to convene HHS components that have a vested interest in US-Mexico border health issues to provide a platform for discussion, coordinate efforts, and potentially identify mutual areas of collaboration to improve the health and quality of life for border residents.
|
|
HHS Coordination Operations and Response Element (previously Operation Warp Speed) (H-CORE/OWS)
|
Research Initiative
|
CDC, FDA, ASPR
|
NIAID
|
A program designed to coordinate and respond to the public health emergency by expediting the development of vaccines, treatments, testing and other measures as needed.
|
|
HHS DATA Act Compliance
|
Committee, Work group, Advisory group, or Task Force
|
ASFR
|
OD/OER, OD/OM/NBS
|
The HHS Assistant Secretary for Financial Resources (ASFR) coordinates OPDIV activities including communications, implementation, and compliance with the DATA Act.
|
|
HHS Data Council
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, ASA, ASFR, ASPA, ASPE, ASPR, ATSDR, CDC, CMS, FDA, GDM, HRSA, IHS, ONC, OMHA
|
OD/OER, NLM, OD/DPCPSI/OBSSR, OD/DPCPSI/ODSS
|
The HHS Data Council is the principal internal advisory body to the Secretary on health and human services data policy. The Council coordinates data collection and analysis activities in HHS, including an integrated data collection strategy as well as coordination of health data standards and privacy policy. The Council consists of senior level officials designated by their agency and staff office heads, the director of the national center for health statistics, and the HHS privacy advocate. It is co-chaired by the Assistant Secretary for Planning and Evaluation on a permanent basis and the head of an operating division on a rotating basis. A subcommittee of the HHS Data Council, the Data-Oriented Workforce Subcommittee, is composed of staff from 10 HHS agencies, including the NIH. This subcommittee is charged with developing a high-level work plan to enhance the data science capacity of HHS’ workforce by identifying training opportunities for existing staff, recruitment strategies and tools to hire new staff, and retention and succession planning strategies to sustain the data science workforce.
|